India pharma loan may be just the cure for M&A lull

Two Indian companies are vying for the UK and Ireland assets of Israeli firm Teva Pharmaceutical Industries and have lined up loan packages to back their bids. Although the results are still some way off, credit starved bankers are excited about the prospects of financing a sizeable acquisition out of India, writes Shruti Chaturvedi.